Cullinan uniquely applies open innovation to the development of scientific  oncology assets. Their approach breaks down silos, encourages new ways of thinking and collaboration, and ultimately turns ideas and inspiration into novel executable therapeutic concepts. Through both internal and external means, they seek to develop first-in-class or best-in-class assets that have the potential to significantly improve the lives of those living with cancer.